{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:07:59Z","timestamp":1785229679183,"version":"3.55.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,9,15]]},"DOI":"10.2169\/internalmedicine.8581-21","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T22:09:49Z","timestamp":1645826989000},"page":"2809-2811","source":"Crossref","is-referenced-by-count":10,"title":["Aseptic Meningitis after Amenamevir Treatment for Herpes Zoster in the First Branch of the Trigeminal Nerve"],"prefix":"10.2169","volume":"61","author":[{"given":"Kazuhiro","family":"Itoh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"},{"name":"Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Mitsuke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Wakahara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyo","family":"Kiriba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kuwata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan"},{"name":"Division of Infection Control and Prevention, University of Fukui Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsutani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Maruho. Characteristics of Amenalief<sup>\u00ae<\/sup> Tablets [Internet]. 2021 [cited 2021 Jun 11]. Available from: https:\/\/www.maruho.co.jp\/medical\/amenalief\/products\/characteristic.html (in Japanese)"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kawashima M, Nemoto O, Honda M, et al. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: a randomized, double-blind, valaciclovir-controlled phase 3 study. J Dermatol 44: 1219-1227, 2017.","DOI":"10.1111\/1346-8138.13948"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ohtsu Y, Susaki Y, Noguchi K. Absorption, distribution, metabolism, and excretion of the novel helicase-primase inhibitor, amenamevir (ASP2151), in rodents. Eur J Drug Metab Pharmacokinet 43: 693-706, 2018.","DOI":"10.1007\/s13318-018-0481-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47: 303-327, 2008.","DOI":"10.1086\/589747"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nagel MA, Forghani B, Mahalingam R, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68: 1069-1073, 2007.","DOI":"10.1212\/01.wnl.0000258549.13334.16"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gregoire SM, van Pesch V, Goffette S, et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry 77: 938-942, 2006.","DOI":"10.1136\/jnnp.2006.090316"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70: 853-860, 2008.","DOI":"10.1212\/01.wnl.0000304747.38502.e8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system - prognosis, diagnostics and treatment. J Infect 71: 281-293, 2015.","DOI":"10.1016\/j.jinf.2015.06.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mukai T, Saiga T, Araki T. Multiple cerebral hemorrhages due to varicella-zoster virus vasculopathy presenting as cranial nerve palsy. Rinsho Shinkeigaku (Clin Neurol) 60: 861-864, 2020 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001462"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shiraki K, Takemoto M, Daikoku T. Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment. Expert Rev Anti Infect Ther 19: 1415-1425, 2021.","DOI":"10.1080\/14787210.2021.1917992"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Blum MR, Liao SH, de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med 73: 186-192, 1982.","DOI":"10.1016\/0002-9343(82)90088-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Skripuletz T, Pars K, Schulte A, et al. Varicella zoster virus infections in neurological patients: a clinical study. BMC Infect Dis 18: 238, 2018.","DOI":"10.1186\/s12879-018-3137-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shoji H, Fukushima Y, Sakoda Y, Abe T, Oguri S, Baba M. Varicella-zoster virus-associated polyradiculoneuritis with concomitant herpes zoster eruption: a case report. Rinsho Shinkeigaku (Clin Neurol) 59: 641-645, 2019 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001302"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Taniguchi Y, Kano Y, Kitamura T, Miura T, Yamada K. Varicella-zoster meningoencephalitis and vasculitis after treatment with amenamevir to herpes zoster in the trigeminal nerve area. Rinsho Shinkeigaku (Clin Neurol) 61: 239-242, 2021 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001531"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/18\/61_8581-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:19:57Z","timestamp":1715231997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/18\/61_8581-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":14,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8581-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"article-number":"8581-21"}}